Global Bioidentical Hormones market size is predicted to grow from US$ 328 million in 2025 to US$ 392 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031. Get Access Now!

Global Bioidentical Hormones Market Size and Outlook 2025-31

The global Bioidentical Hormones market size is predicted to grow from US$ 328 million in 2025 to US$ 392 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Bioidentical hormones are hormones that are chemically the same as those that the body produces. Although they are made in a laboratory, bioidentical hormones mimic the hormones the human body produces naturally. United States market for Bioidentical Hormones is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Bioidentical Hormones is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Bioidentical Hormones is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Bioidentical Hormones players cover SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Bioidentical Hormones Industry Forecast looks at past sales and reviews total world Bioidentical Hormones sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioidentical Hormones sales for 2025 through 2031. With Bioidentical Hormones sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioidentical Hormones industry. This Insight Report provides a comprehensive analysis of the global Bioidentical Hormones landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioidentical Hormones portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Bioidentical Hormones market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioidentical Hormones and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioidentical Hormones. This report presents a comprehensive overview, market shares, and growth opportunities of Bioidentical Hormones market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Estrogens &nbsp;&nbsp;&nbsp; Progesterone &nbsp;&nbsp;&nbsp; Testosterone &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals & Gynecology Clinics &nbsp;&nbsp;&nbsp; Academic and Research &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; SottoPelle &nbsp;&nbsp;&nbsp; BioTE Medical &nbsp;&nbsp;&nbsp; Advantage Pharmaceuticals &nbsp;&nbsp;&nbsp; Full Life Wellness Center &nbsp;&nbsp;&nbsp; Neuva Aesthetics &nbsp;&nbsp;&nbsp; Defy Medical &nbsp;&nbsp;&nbsp; Biostation Key Questions Addressed in this Report What is the 10-year outlook for the global Bioidentical Hormones market? What factors are driving Bioidentical Hormones market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Bioidentical Hormones market opportunities vary by end market size? How does Bioidentical Hormones break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Bioidentical Hormones Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Bioidentical Hormones by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Bioidentical Hormones by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Bioidentical Hormones Segment by Type &nbsp;2.2.1 Estrogens &nbsp;2.2.2 Progesterone &nbsp;2.2.3 Testosterone &nbsp;2.2.4 Others &nbsp;2.3 Bioidentical Hormones Sales by Type &nbsp;2.3.1 Global Bioidentical Hormones Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Bioidentical Hormones Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Bioidentical Hormones Sale Price by Type (2020-2025) &nbsp;2.4 Bioidentical Hormones Segment by Application &nbsp;2.4.1 Hospitals & Gynecology Clinics &nbsp;2.4.2 Academic and Research &nbsp;2.4.3 Others &nbsp;2.5 Bioidentical Hormones Sales by Application &nbsp;2.5.1 Global Bioidentical Hormones Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Bioidentical Hormones Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Bioidentical Hormones Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Bioidentical Hormones Breakdown Data by Company &nbsp;3.1.1 Global Bioidentical Hormones Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Bioidentical Hormones Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Bioidentical Hormones Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Bioidentical Hormones Revenue by Company (2020-2025) &nbsp;3.2.2 Global Bioidentical Hormones Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Bioidentical Hormones Sale Price by Company &nbsp;3.4 Key Manufacturers Bioidentical Hormones Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Bioidentical Hormones Product Location Distribution &nbsp;3.4.2 Players Bioidentical Hormones Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Bioidentical Hormones by Geographic Region &nbsp;4.1 World Historic Bioidentical Hormones Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Bioidentical Hormones Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Bioidentical Hormones Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Bioidentical Hormones Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Bioidentical Hormones Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Bioidentical Hormones Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Bioidentical Hormones Sales Growth &nbsp;4.4 APAC Bioidentical Hormones Sales Growth &nbsp;4.5 Europe Bioidentical Hormones Sales Growth &nbsp;4.6 Middle East & Africa Bioidentical Hormones Sales Growth 5 Americas &nbsp;5.1 Americas Bioidentical Hormones Sales by Country &nbsp;5.1.1 Americas Bioidentical Hormones Sales by Country (2020-2025) &nbsp;5.1.2 Americas Bioidentical Hormones Revenue by Country (2020-2025) &nbsp;5.2 Americas Bioidentical Hormones Sales by Type (2020-2025) &nbsp;5.3 Americas Bioidentical Hormones Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Bioidentical Hormones Sales by Region &nbsp;6.1.1 APAC Bioidentical Hormones Sales by Region (2020-2025) &nbsp;6.1.2 APAC Bioidentical Hormones Revenue by Region (2020-2025) &nbsp;6.2 APAC Bioidentical Hormones Sales by Type (2020-2025) &nbsp;6.3 APAC Bioidentical Hormones Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Bioidentical Hormones by Country &nbsp;7.1.1 Europe Bioidentical Hormones Sales by Country (2020-2025) &nbsp;7.1.2 Europe Bioidentical Hormones Revenue by Country (2020-2025) &nbsp;7.2 Europe Bioidentical Hormones Sales by Type (2020-2025) &nbsp;7.3 Europe Bioidentical Hormones Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Bioidentical Hormones by Country &nbsp;8.1.1 Middle East & Africa Bioidentical Hormones Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Bioidentical Hormones Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Bioidentical Hormones Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Bioidentical Hormones Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Bioidentical Hormones &nbsp;10.3 Manufacturing Process Analysis of Bioidentical Hormones &nbsp;10.4 Industry Chain Structure of Bioidentical Hormones 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Bioidentical Hormones Distributors &nbsp;11.3 Bioidentical Hormones Customer 12 World Forecast Review for Bioidentical Hormones by Geographic Region &nbsp;12.1 Global Bioidentical Hormones Market Size Forecast by Region &nbsp;12.1.1 Global Bioidentical Hormones Forecast by Region (2026-2031) &nbsp;12.1.2 Global Bioidentical Hormones Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Bioidentical Hormones Forecast by Type (2026-2031) &nbsp;12.7 Global Bioidentical Hormones Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 SottoPelle &nbsp;13.1.1 SottoPelle Company Information &nbsp;13.1.2 SottoPelle Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.1.3 SottoPelle Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 SottoPelle Main Business Overview &nbsp;13.1.5 SottoPelle Latest Developments &nbsp;13.2 BioTE Medical &nbsp;13.2.1 BioTE Medical Company Information &nbsp;13.2.2 BioTE Medical Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.2.3 BioTE Medical Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 BioTE Medical Main Business Overview &nbsp;13.2.5 BioTE Medical Latest Developments &nbsp;13.3 Advantage Pharmaceuticals &nbsp;13.3.1 Advantage Pharmaceuticals Company Information &nbsp;13.3.2 Advantage Pharmaceuticals Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.3.3 Advantage Pharmaceuticals Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Advantage Pharmaceuticals Main Business Overview &nbsp;13.3.5 Advantage Pharmaceuticals Latest Developments &nbsp;13.4 Full Life Wellness Center &nbsp;13.4.1 Full Life Wellness Center Company Information &nbsp;13.4.2 Full Life Wellness Center Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.4.3 Full Life Wellness Center Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Full Life Wellness Center Main Business Overview &nbsp;13.4.5 Full Life Wellness Center Latest Developments &nbsp;13.5 Neuva Aesthetics &nbsp;13.5.1 Neuva Aesthetics Company Information &nbsp;13.5.2 Neuva Aesthetics Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.5.3 Neuva Aesthetics Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Neuva Aesthetics Main Business Overview &nbsp;13.5.5 Neuva Aesthetics Latest Developments &nbsp;13.6 Defy Medical &nbsp;13.6.1 Defy Medical Company Information &nbsp;13.6.2 Defy Medical Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.6.3 Defy Medical Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Defy Medical Main Business Overview &nbsp;13.6.5 Defy Medical Latest Developments &nbsp;13.7 Biostation &nbsp;13.7.1 Biostation Company Information &nbsp;13.7.2 Biostation Bioidentical Hormones Product Portfolios and Specifications &nbsp;13.7.3 Biostation Bioidentical Hormones Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Biostation Main Business Overview &nbsp;13.7.5 Biostation Latest Developments 14 Research Findings and Conclusion

Report	Global Bioidentical Hormones Market Growth 2025-2031
Selected License	Multi ID: LPI23543

Buyer Information

Order Summary